Today

Agents

Chat

Arena

Discover

More

App

Trevi Therapeutics Q2 Net Income USD -17.797 Million - TRVI News | Rallies

Trevi Therapeutics Q2 Net Income USD -17.797 Million

TRVI•2026-08-06

Q2 results

Aug 06 (Reuters) - Trevi Therapeutics Q2 income from operations USD -20.509 million.

Q2 pretax profit USD -17.816 million
Q2 operating expenses USD 20.509 million
Q2 EPS USD -0.11

Related News

Canada's CAPREIT Q2 revenue slightly beats driven by increased monthly rents on lease renewals

XLRE•2026-08-06

ZenaTech begins flight testing Interceptor P-1 counter-drone platform, targets price under USD 5,000

ZENA•2026-08-06

Canada's Wheaton Precious Metals Q2 revenue misses estimates

WPM

•

2026-08-06

Coda Octopus Group announces annual shareholder meeting

CODA•2026-08-06

Sunoco to buy Offen Petroleum for USD 600 million in cash

SUN•2026-08-06